The Vanguard Group, Inc. recently announced the acquisition of new stake in Johnson Controls International plc (NYSE:JCI). The institutional investor has increased its shareholding in the Industrials company by 23.24% to 71.39 million shares with purchase of 13.46 million shares. This fresh investment now brings its stake to 10.49% valued currently at $4.11 billion. In addition, Dodge & Cox raised its holdings by 2.3 million to 63.7 million shares. And BlackRock Fund Advisors has lifted its position by 1.03% or 0.31 million shares – to 30.39 million shares.
Currently, there are 680.37M common shares owned by the public and among those 675.54M shares have been available to trade.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Insiders at the company have transacted a total of 38 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 16 of these insider trades were purchases, accounting for 413,221 shares. Insider sales of the common stock occurred on 22 occasions, with total insider shares sold totaling 444,145 shares.
The top 3 mutual fund holders in Johnson Controls International plc are Dodge & Cox Stock Fund, Vanguard Total Stock Market ETF, and Vanguard 500 Index Fund. Dodge & Cox Stock Fund owns 31.56 million shares of the company’s stock, all valued at over $1.82 billion. The company bought an additional 0.17 million shares recently to bring their total holdings to about 4.64% of the shares outstanding. Vanguard Total Stock Market ETF bought 16822.0 shares to see its total holdings expand to 21.33 million shares valued at over $1.23 billion and representing 3.13% of the shares outstanding. Vanguard 500 Index Fund bought 29664.0 shares to bring its total holdings to over 16.61 million shares at a value of $957.45 million. Vanguard 500 Index Fund now owns shares totaling to 2.44% of the shares outstanding.
However, the script later moved the day high at 55.67, up 1.35%. The company’s stock has a 5-day price change of 6.18% and 14.23% over the past three months. JCI shares are trading -3.47% year to date (YTD), with the 12-month market performance down to -15.76% lower. It has a 12-month low price of $47.90 and touched a high of $70.43 over the same period. JCI has an average intraday trading volume of 5.89 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -1.19%, 2.32%, and -4.66% respectively.
Institutional ownership of Johnson Controls International plc (NYSE: JCI) shares accounts for 92.32% of the company’s 680.37M shares outstanding. Mutual fund holders own 36.21%, while other institutional holders and individual stakeholders account for 57.15% and 0.79% respectively.
It has a market capitalization of $37.87B and a beta (3y monthly) value of 1.23. The stock’s trailing 12-month PE ratio is 20.64, while the earnings-per-share (ttm) stands at $2.70. The company has a PEG of 1.68 and a Quick Ratio of 0.70 with the debt-to-equity ratio at 0.62. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.57% over the week and 2.13% over the month.
Analysts forecast that Johnson Controls International plc (JCI) will achieve an EPS of $0.51 for the current quarter, $0.78 for the next quarter and $4.17 for 2025. The lowest estimate earnings-per-share for the quarter is $0.49 while analysts give the company a high EPS estimate of $0.56. Comparatively, EPS for the current quarter was $0.67 a year ago. Earnings per share for the fiscal year are expected to increase by 4.63%, and 13.97% over the next financial year. EPS should grow at an annualized rate of 12.25% over the next five years, compared to 3.00% over the past 5-year period.
Looking at the support for the JCI, a number of firms have released research notes about the stock. RBC Capital Mkts stated their Underperform rating for the stock in a research note on January 12, 2024, with the firm’s price target at $54-$50.
